Evidence mapPaperPMID 26718207Full record

GuidelineJournal of endocrinological investigation2016

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

M G Baroni, F Giorgino, V Pezzino, C Scaroni, A Avogaro

Abstract readPractice GuidelineSystematic Review
PubMed Publisher
In one paragraph

Guideline in Journal of endocrinological investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Perioperative Management of a Patient With Cushing Disease.Journal of the Endocrine Society · 2022
    Article
  5. Review
  6. Glucose metabolism in Cushing's syndrome.Current opinion in endocrinology, diabetes, and obesity · 2020
    Review
  7. Review
  8. Article
  9. Diabetes Mellitus Secondary to Cushing's Disease.Frontiers in endocrinology · 2018
    Review
  10. Review
  11. Diabetes in Cushing Disease.Current diabetes reports · 2017
    Review
  12. Risk of malignant neoplasms in acromegaly: a case-control study.Journal of endocrinological investigation · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

M G BaroniEndocrinology and Diabetes, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
F GiorginoSection of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy.
V PezzinoEndocrinology, Department of Clinical and Molecular Bio-Medicine, Cannizzaro Hospital, University of Catania, Catania, Italy.
C ScaroniSection of Endocrinology, Department of Medicine, University of Padova, Padua, Italy.
A AvogaroSection of Metabolic Diseases, Department of Medicine, University of Padova, Via Giustiniani, 2, 3128, Padua, Italy. angelo.avogaro@unipd.it.
University of Padua · ITSapienza University of Rome · ITUniversity of Bari Aldo Moro · ITUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic decisions for the treatment of hyperglycemia in patients with growth hormone and corticosteroid excess. Both the SID and SIE appointed members to represent each society and to collaborate in Guidelines writing. Members were chosen for their specific knowledge in the field. Each member agreed to produce-and regularly update-conflicts of interest. The authors of these guidelines prepared their contributions following the recommendations for the development of Guidelines, using the standard classes of recommendation shown below. All members of the writing committee provided editing and systematic review of each part of the manuscript, and discussed the grading of evidence. Consensus was guided by a systematic review of all available trials and by interactive discussions.

Indexed as

Evidence-Based MedicinePrecision MedicineAcromegalyCombined Modality TherapyConsensusCushing SyndromeDiabetes MellitusEndocrinologyGlucocorticoidsHuman Growth HormoneHumansHyperglycemiaItalySocieties, ScientificGlucocorticoidsHuman Growth HormoneAntidiabetic treatmentDiabetesDopamine agonistsGH hypersecretionGlucocorticoid excessPegvisomantSomatostatin agonistsSteroid treatment

Identifiers

PMID26718207
OpenAlexW2277055097

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.